The efficacy and uniqueness of the Mirragen product lies in its special composition. It is a biomaterial that is similar in structure to a natural fibrin clot that is formed in all wounds during their healing phase. The cause of trophic wounds on the patient's leg in diabetes is impaired metabolic processes and microcirculation in the affected area. This is also a consequence of poor wound healing.
Mirragen has a wide range of useful pharmacological activities, making it more effective even in cases where the strongest drugs can not accelerate wound healing.
Biomaterial is used as a normal dressing by placing a piece of the required size on the wound. Immediately after entering the damaged cavity, the bioactive fibers react with the natural exudate and promote the excretion of active electrolytes into the wound. After a while, the biomaterial changes its appearance, indicating that it is working properly.
Mirragen active fibers act as a framework to which natural fibrin clots attach. This accelerates the healing process by about 40% compared to other treatments.
Mirragen largely benefits from other wound healing and disinfectants, and has many benefits:
Medivo is the exclusive representative of the Mirragen product in Ukraine. We offer fast delivery of quality remedy from America, as well as free consultations on material properties not only for doctors, but also for non-specialists.